JP2020510616A5 - - Google Patents

Download PDF

Info

Publication number
JP2020510616A5
JP2020510616A5 JP2019528748A JP2019528748A JP2020510616A5 JP 2020510616 A5 JP2020510616 A5 JP 2020510616A5 JP 2019528748 A JP2019528748 A JP 2019528748A JP 2019528748 A JP2019528748 A JP 2019528748A JP 2020510616 A5 JP2020510616 A5 JP 2020510616A5
Authority
JP
Japan
Prior art keywords
inhibitor
composition
dpp
shock wave
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019528748A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020510616A (ja
JP7231543B2 (ja
Filing date
Publication date
Priority claimed from GBGB1619861.6A external-priority patent/GB201619861D0/en
Application filed filed Critical
Publication of JP2020510616A publication Critical patent/JP2020510616A/ja
Publication of JP2020510616A5 publication Critical patent/JP2020510616A5/ja
Application granted granted Critical
Publication of JP7231543B2 publication Critical patent/JP7231543B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019528748A 2016-11-24 2017-11-17 心不全および心臓虚血再灌流障害の治療 Active JP7231543B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1619861.6A GB201619861D0 (en) 2016-11-24 2016-11-24 Treatments for heart failure and cardiac ischaemic reperfusion injury
GB1619861.6 2016-11-24
PCT/GB2017/053473 WO2018096319A1 (en) 2016-11-24 2017-11-17 Treatments for heart failure and cardiac ischaemic reperfusion injury

Publications (3)

Publication Number Publication Date
JP2020510616A JP2020510616A (ja) 2020-04-09
JP2020510616A5 true JP2020510616A5 (https=) 2021-10-28
JP7231543B2 JP7231543B2 (ja) 2023-03-01

Family

ID=58073526

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019528748A Active JP7231543B2 (ja) 2016-11-24 2017-11-17 心不全および心臓虚血再灌流障害の治療

Country Status (16)

Country Link
US (1) US20190374623A1 (https=)
EP (1) EP3544624B1 (https=)
JP (1) JP7231543B2 (https=)
KR (1) KR102678011B1 (https=)
CN (1) CN109996558A (https=)
AU (1) AU2017365926B2 (https=)
CA (1) CA3044624A1 (https=)
ES (1) ES3017482T3 (https=)
GB (1) GB201619861D0 (https=)
HR (1) HRP20250664T1 (https=)
HU (1) HUE071244T2 (https=)
MY (1) MY200960A (https=)
PL (1) PL3544624T3 (https=)
RS (1) RS66778B9 (https=)
RU (1) RU2767445C2 (https=)
WO (1) WO2018096319A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023281447A1 (en) * 2021-07-07 2023-01-12 Radius Health, Inc. Methods of treating a cardiovascular ischemic event
US20240122794A1 (en) * 2022-10-12 2024-04-18 Softwave Tissue Regeneration Technologies, Inc. Acoustic shock wave or pressure pulse treatment and methods of use for anti-aging
CN115998768B (zh) * 2023-02-07 2024-01-30 西南医科大学 M2型巨噬细胞外泌体在制备治疗心肌缺血再灌注损伤药物中的应用
CN117257785A (zh) * 2023-11-09 2023-12-22 新疆医科大学 没食子酸及其衍生物在制备预防和/或治疗心肌损伤药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2007416T3 (pl) * 2006-04-19 2018-05-30 Ludwig-Maximilians-Universität München Parathormon (PTH) do zastosowania w leczeniu niedokrwienia
US8455435B2 (en) * 2006-04-19 2013-06-04 Ludwig-Maximilians-Universitat Munchen Remedies for ischemia
MX2011009852A (es) * 2009-03-27 2011-09-29 Bristol Myers Squibb Co Metodos para prevenir episodios cardiovasculares adversos mayores con inhibidores de dipeptidil peptidasa iv.
EP3110449B1 (en) * 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor

Similar Documents

Publication Publication Date Title
Migliore et al. Myocardial edema underlies dynamic T-wave inversion (Wellens' ECG pattern) in patients with reversible left ventricular dysfunction
Kuethe et al. Treatment with granulocyte colony–stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction
Wang et al. Cardiac involvement in Emery-Dreifuss muscular dystrophy and related management strategies
JP2020510616A5 (https=)
Cassar et al. Safety and efficacy of extracorporeal shock wave myocardial revascularization therapy for refractory angina pectoris
Cetin et al. Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results, Cardiovascular Journal of Africa 25 (4) 2014: pp. 168-175
RU2019119110A (ru) Способы лечения сердечной недостаточности и ишемического- реперфузионного повреждения сердца
Becker et al. Myocardial effects of local shock wave therapy in a Langendorff model
Masson et al. Effect of continuous and interval aerobic exercise training on baroreflex sensitivity in heart failure
Babalis et al. Effects of ranolazine on left ventricular diastolic and systolic function in patients with chronic coronary disease and stable angina
Miyazawa et al. Presence of ventricular aneurysm predicts poor clinical outcomes in patients with cardiac sarcoidosis
WO2004112565A3 (en) Diagnosis and treatment of liver, pulmonary and cardiac fibrosis
Saito et al. Simultaneous multivessel coronary spasm causing acute myocardial infarction: a case report
Shah et al. Stem cell therapy for acute myocardial infarction-long term 24 months follow-up
Zagorulko et al. Integrative methods of diagnosis and treatment of the chronical pain
Leone et al. Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study
Lee et al. Heart conditioning as healthy strategy in management of aortic stenosis: A case report. Cardiac and Cardiovascular Research. 2024; 5 (2): 3010
Dulsat European Society of Cardiology (ESC) Congress 2019. Paris, France-August 31-September 4, 2019
Kanorskii et al. Sacubitril/valsartan versus candesartan in women with heart failure receiving adjuvant therapy for breast cancer-is there any antiarrhythmic effect?
Cherif et al. Alcohol septal ablation after suboptimal surgical septal myomectomy
Erzsebet et al. Double Hematological and Cardiologic Benefits of Autologous Stem Cell Transplantation in a Case of stage III B IgG Myeloma multiplex and Dilatative Cardiomyopathy–a Case Report
Wang et al. An unusual case of fulminant myocarditis closely mimicking ST-segment elevation myocardial infarction and presenting as refractory cardiogenic shock complicated by multiple life-threatening arrhythmiasAn unusual case of fulminant myocarditis
Demirci et al. Long-Term Cardiovascular Mortality After Radiotherapy for Breast Cancer: Bouillon K, Haddy N, Delaloge S, et al (Radiation Epidemiology Group-CESP—Unit 1018 INSERM, Villejuif, France; Institut Gustave Roussy, Villejuif, France; et al) J Am Coll Cardiol 57: 445-452, 2011
M-Castillo et al. EFFECT OF MANIDIPINE IN CHRONIC KIDNEY DISEASE PATIENTS WITH METABOLIC SYNDROME. PLASENCIA STUDY: PP. 34.399
Kiavar et al. Is there any positive remodeling after enhanced external counter pulsation in patients with severe refractory angina?